Cargando…
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib
BACKGROUND: Tyrosine kinase inhibitors (TKIs) are currently approved for the treatment of metastatic renal cell carcinoma (mRCC). The cardiotoxic effects of sorafenib and sunitinib may cause hypertension, left ventricular ejection fraction (LVEF) dysfunction and/or congestive heart failure (CHF), an...
Autores principales: | Pantaleo, Maria Abbondanza, Mandrioli, Anna, Saponara, Maristella, Nannini, Margherita, Erente, Giovanna, Lolli, Cristian, Biasco, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407789/ https://www.ncbi.nlm.nih.gov/pubmed/22687270 http://dx.doi.org/10.1186/1471-2407-12-231 |
Ejemplares similares
-
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor
por: Lolli, Cristian, et al.
Publicado: (2011) -
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours
por: SAPONARA, MARISTELLA, et al.
Publicado: (2014) -
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib
por: Pallotti, Maria Caterina, et al.
Publicado: (2012) -
Three cases of bone metastases in patients with gastrointestinal stromal tumors
por: Di Scioscio, Valerio, et al.
Publicado: (2011) -
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)
por: Saponara, Maristella, et al.
Publicado: (2015)